Funding history
The United States is one of the Vaccine Alliance’s original six donor countries and contributes to Gavi through direct contributions. The United States has placed a significant emphasis on ending preventable child deaths through reducing child mortality and targeting funding for high-impact, low-cost interventions. Vaccines and immunizations are an important component of this initiative and Gavi is a key partner in helping the United States achieve its goals. Moreover, the United States continues to be an important partner to Gavi by aligning programmatic interests incountry to ensure greater efficiency and impact on the ground.
Annual contributions have increased from USD 48 million in 2001 to USD 275 million in 2017. At Gavi’s first pledging conference in June 2011, the United States pledged USD 450 million for the period 2012-2014, subject to congressional approval. In addition to this pledge announcement, the US contributed USD 90 million for 2011. At the Gavi pledging conference in January 2015, the United States pledged USD 1 billion for the period 2015-2018, subject to congressional approval, which includes the 2017 contribution of USD 275 million. The 2017 funding level represents the largest annual contribution to the Vaccine Alliance from the United States to date.
Contributions and pledges in total:
- Direct funding (2001-2014): USD 1.2 billion;
- New pledge (2015-2018): USD 1 billion;
- Ebola (2017-2020): USD 20 million.